These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 34098082

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K/Akt/mTOR signaling pathways to activate P53 and induce apoptosis.
    Chen NY, Lu K, Yuan JM, Li XJ, Gu ZY, Pan CX, Mo DL, Su GF.
    Bioorg Chem; 2021 Sep; 114():105101. PubMed ID: 34175723
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Arctigenin Triggers Apoptosis and Autophagy via PI3K/Akt/mTOR Inhibition in PC-3M Cells.
    Sun BL, Cai EB, Zhao Y, Wang Y, Yang LM, Wang JY.
    Chem Pharm Bull (Tokyo); 2021 May 01; 69(5):472-480. PubMed ID: 33627540
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents.
    Wu GR, Xu B, Yang YQ, Zhang XY, Fang K, Ma T, Wang H, Xue NN, Chen M, Guo WB, Jia XH, Wang PL, Lei HM.
    Eur J Med Chem; 2018 Jul 15; 155():183-196. PubMed ID: 29886322
    [Abstract] [Full Text] [Related]

  • 8. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
    Shareef MA, Duscharla D, Ramasatyaveni G, Dhoke NR, Das A, Ummanni R, Srivastava AK.
    Eur J Med Chem; 2015 Jan 07; 89():128-37. PubMed ID: 25462233
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design, Synthesis, and Antitumor Activity of Isoliquiritigenin Amino Acid Ester Derivatives.
    Liu C, Liu X, Ma Q, Su F, Cai E.
    Molecules; 2024 Jun 03; 29(11):. PubMed ID: 38893517
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents.
    Sun WX, Ji YJ, Wan Y, Han HW, Lin HY, Lu GH, Qi JL, Wang XM, Yang YH.
    Bioorg Med Chem Lett; 2017 Sep 01; 27(17):4066-4074. PubMed ID: 28757065
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Derivatives of Deoxypodophyllotoxin Induce Apoptosis through Bcl-2/Bax Proteins Expression.
    Li YN, Ning N, Song L, Geng Y, Fan JT, Ma CY, Jiang HZ.
    Anticancer Agents Med Chem; 2021 Sep 01; 21(5):611-620. PubMed ID: 32748757
    [Abstract] [Full Text] [Related]

  • 14. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
    Abbas SH, Abd El-Hafeez AA, Shoman ME, Montano MM, Hassan HA.
    Bioorg Chem; 2019 Feb 01; 82():360-377. PubMed ID: 30428415
    [Abstract] [Full Text] [Related]

  • 15. BF12, a Novel Benzofuran, Exhibits Antitumor Activity by Inhibiting Microtubules and the PI3K/Akt/mTOR Signaling Pathway in Human Cervical Cancer Cells.
    Gao Y, Ma C, Feng X, Liu Y, Haimiti X.
    Chem Biodivers; 2020 Mar 01; 17(3):e1900622. PubMed ID: 31951313
    [Abstract] [Full Text] [Related]

  • 16. Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells.
    An X, Wei Z, Ran B, Tian H, Gu H, Liu Y, Cui H, Zhu S.
    Anticancer Agents Med Chem; 2020 Mar 01; 20(17):2114-2124. PubMed ID: 32593284
    [Abstract] [Full Text] [Related]

  • 17. Sinomenine Derivatives: Synthesis, Antitumor Activity, and Apoptotic Induction in MCF-7 Cells via IL-6/PI3K/Akt/NF-κB Signaling Pathway.
    Zhu Z, Zhou H, Chen F, Deng J, Yin L, He B, Hu Q, Wang T.
    ChemMedChem; 2022 Jul 19; 17(14):e202200234. PubMed ID: 35612514
    [Abstract] [Full Text] [Related]

  • 18. Indirubin, an Active Component of Indigo Naturalis, Exhibits Inhibitory Effects on Leukemia Cells via Targeting HSP90AA1 and PI3K/Akt Pathway.
    Yao Y, Li X, Yang X, Mou H, Wei L.
    Anticancer Agents Med Chem; 2024 Jul 19; 24(9):718-727. PubMed ID: 38347773
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.